Overview

Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer

Status:
Completed

Trial end date:
2020-05-19

Target enrollment:

Participant gender:

Summary

This is randomized , open-label, multiple-dose, parallel study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG-651" in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

CrystalGenomics, Inc.

Treatments:

Pregabalin